HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export services. It has established a "1+2+3+4=1" service system and can supply original factory goods from multiple well-known brands of Plant Sterols.

Adopting an operation model of "1+1>2", HiSiaddi focuses on the integrated development of technology transformation and export business. It consistently monitors the global Plant Sterols market from both scientific research and market perspectives. Today, we will conduct a professional analysis of the latest shifts and trends in the global Plant Sterols market.

If you need more comprehensive and valuable market information about Plant Sterols, please contact HiSiaddi customer service.

I. Five Core New Trends of the Global Plant Sterols Market (2025–2026)

(I) Sustained High Market Growth, Asia-Pacific as the Core Growth Engine

The global plant sterols market reached USD 1.1 billion in 2025, is projected to rise to USD 1.2 billion in 2026, and will climb to USD 2.6 billion by 2035, with a compound annual growth rate (CAGR) of 8.7% from 2026 to 2035. Meanwhile, the plant sterol ester market recorded a size of USD 1.07 billion in 2025 and is expected to hit USD 1.95 billion by 2035 at a CAGR of 6.2%.

Regional landscape restructuring: Europe remains the largest market (accounting for 32% in 2035), while the Asia-Pacific region (China, India, Japan, South Korea) emerges as the fastest-growing area thanks to rising health awareness, policy support and capacity expansion. China’s export volume hit RMB 320 million in 2025, a year-on-year increase of 19.6%, with major destinations including the EU, the United States and Southeast Asia.

(II) High-End Upgrading of Product Mix, High Purity and Customization Become Mainstream

The market is shifting from "crude bulk commodities" to high-purity, high-value-added and customized products:

1. Higher purity thresholds: The mainstream purity standard for food-grade products has risen from 90% to above 95%. The pharmaceutical, special medical food and infant food sectors require a minimum purity of 98%, and high-purity (≥99%) monooleate plant sterols posted an export average price of RMB 864,000 per ton, up 4.2% year-on-year.

2. Distinct formulation differentiation: Powder forms will account for 58% of the market by 2035, driven by rigid demand from food, health supplements and pharmaceuticals; liquid forms target beverages, emulsions and other application scenarios.

3. Surge in customized demands: Downstream buyers no longer settle for generic products, instead requesting customized sterol monomer ratios (sitosterol / campesterol / stigmasterol proportions), customized esterification types (oleate / stearate), and functional modification customization (microencapsulation / nanoemulsification to boost solubility).

(III) Structural Expansion of Application Scenarios, Pharmaceuticals and Cosmetics as New High-Growth Segments

Growth in traditional edible oil fortification applications (68.3% penetration rate) is slowing down, while high-value-added sectors are booming:

1. Pharmaceutical sector: The largest application segment at 32.5% market share, used in lipid-lowering drugs and cardiovascular prevention preparations. EFSA and FDA have confirmed that a daily intake of 2–3 grams can reduce LDL cholesterol by 8–12%, and clinical data fuels rigid demand growth.

2. Cosmetic sector: The fastest-growing track (22.6% year-on-year growth in 2025), focusing on skin barrier repair, anti-inflammation and anti-sensitivity. Leading brands including Bloomage Biotech, Winona and Proya have adopted large-scale addition of plant sterols, with monthly sales of single products exceeding RMB 100 million.

3. New functional foods: Meal replacement bars, nutritional gummy candies, plant-based beverages and special medical foods represent new growth drivers, with purchasing volume of related products rising 35% year-on-year in 2025.

(IV) Rising Global Compliance Barriers, International Certifications Become Mandatory for Overseas Expansion

Global regulatory standards are tightening, pushing up compliance costs and entry thresholds simultaneously:

1. Mandatory core certifications for Europe and the US: EU EFSA health claim certification (requiring minimum daily intake of 2 grams and long-term human clinical data), US FDA GRAS certification, and FCC/E418 standards are prerequisites for market access in Europe and the US. Only 8 enterprises obtained EFSA certification and 11 secured FDA certification in 2025, with a 41.3% rejection rate for unqualified applicants.

2. China’s standards align with international norms: The 2026 revised draft of the Healthy China 2030 Nutrition & Health Standards lists plant sterols as a recommended ingredient for cardiovascular health, while advancing mutual recognition of testing methods and data between China and the EU, as well as China and the US.

3. Environmental and traceability compliance: EU REACH regulations, life cycle assessment (LCA) carbon footprint certification, non-GMO certification and full-chain traceability have become core procurement requirements for high-end buyers.

(V) Restructured Supply Chain Landscape, China Dominates Production Capacity with Tiered Technological Competition

1. China leads global production capacity: China’s annual output reached 32,000 tons in 2025, accounting for 35% of global capacity. Eastern China hosts 60% of total production capacity with leading technology, while low-cost production bases in central and western China are expanding rapidly (12%–15% lower costs), strengthening price flexibility.

2. Competition dimension upgrade: Market competition has shifted from price wars to comprehensive rivalry covering technology, service, compliance and supply chain resilience. Top manufacturers master core technologies such as molecular-level purification and dual-membrane separation, while small and medium-sized enterprises focus on low-end bulk commodity markets.

3. Transformation of trade models: Exporters are shifting from bulk crude product shipments to integrated cooperation covering customized high-value-added products, technical services and compliance support.

II. Core Challenges and Opportunities for Different Downstream B-End Buyers

(I) Food / Functional Beverage Buyers (Largest Application Sector)

Core Challenges

1. Difficulty balancing cost and quality: Prices of high-purity products are rising, while low-grade materials suffer poor solubility and unpleasant taste, causing sediment and off-flavors that damage end-consumer experience.

2. Risks in compliance and health claims: Europe and the US impose strict audits on health claims; under-dosed ingredients or incomplete clinical data may lead to product removal from shelves. Domestic label specification standards are tightening, with heavy fines for violations.

3. Severe homogeneous competition: Conventional edible oil and ordinary health supplement formulations lack differentiation, weakening end-product premium power and squeezing profit margins via price wars.

Core Opportunities

1. Dividend from health consumption: Cardiovascular diseases cause 19.8 million deaths worldwide annually, driving surging consumer demand for proactive prevention. Functional foods fortified with plant sterols can command a 20%–30% price premium.

2. New carrier growth potential: Plant-based beverages, meal replacements, gummy candies and sparkling water have low market penetration, and differentiated formulas can capture market share rapidly.

3. Regional market penetration: Rising health awareness in Southeast Asia, the Middle East and Latin America creates incremental blue ocean markets with lower compliance thresholds.

(II) Health Supplement / Dietary Supplement Buyers (Fastest-Growing Segment, CAGR 9.2%)

Core Challenges

1. Difficulty building trust in efficacy and safety: Consumers doubt the cholesterol-lowering efficacy, requiring clinical data as supporting evidence. Safety disputes over oxidized products (POPs) hinder acceptance in high-end markets.

2. Insufficient formulation compatibility: Plant sterols have poor water solubility and low bioavailability (<5%), leading to low repurchase rates for standard tablets and capsules due to low absorption efficiency.

3. Complex cross-border compliance: Varying dosage standards, labeling requirements and certification procedures across countries push up compliance costs for small-batch procurement.

Core Opportunities

1. Booming demand for precision health: Middle-aged and elderly populations, hyperlipidemia groups and weight-loss consumers form core target groups; customized compound formulas (sterols + fish oil + dietary fiber) deliver high premiums.

2. Ample space for formulation innovation: Microencapsulated powders, nanoemulsions, gummy candies and oral liquids improve absorption and taste, creating clear differentiation advantages.

3. Dividend from online channels: The rise of cross-border e-commerce and DTC brands allows small and medium buyers to reach end consumers directly, cutting intermediate links and boosting profits.

(III) Cosmetic / Skincare Buyers (22.6% Growth Rate, High-Value Track)

Core Challenges

1. Difficulty verifying efficacy and formulation compatibility: Third-party test reports are required to validate the anti-inflammatory and barrier-repair effects of sterol esters; poor compatibility with ceramides, squalane and other ingredients causes stratification and discoloration.

2. Strict control over purity and impurities: Cosmetic-grade standards mandate ultra-low limits for heavy metals, microorganisms and solvent residues; crude materials may trigger skin irritation and consumer complaints.

3. Slow supply chain response: Customized esterified products (e.g., isostearate, hydroxystearate) have limited production capacity, with long lead times (45–60 days) for small-batch orders.

Core Opportunities

1. Boom in efficacy skincare: Expanding global populations with sensitive skin and damaged skin barriers drive strong demand for mild plant-derived ingredients, making sterol esters core components for high-end repair products.

2. Domestic substitution and overseas expansion: China’s mature cosmetic supply chain enables brands to launch cost-effective sterol ester-based products for overseas markets, with high acceptance in Southeast Asia and Europe.

3. Expansion into segmented scenarios: Infant skincare, medical beauty repair and men’s skincare tracks have low penetration rates, offering first-mover advantages.

(IV) Pharmaceutical / Special Medical Food Buyers (Highest Barriers, High-Profit Track)

Core Challenges

1. Extremely high technical and compliance barriers: Products require ≥98% purity, sterile-grade standards and full-batch quality inspection reports; EU CEP and US DMF certifications take 2–3 years to obtain with heavy R&D investment.

2. Stringent supply chain stability requirements: Zero tolerance for quality risks in special medical foods and infant formula; suppliers must demonstrate robust production capacity, quality control and traceability systems.

3. Low price sensitivity yet heavy cost pressure: While high-end markets show limited price elasticity, purification, raw material and testing costs remain high, requiring long-term cooperative partnerships to reduce expenses.

Core Opportunities

1. Inelastic demand with strong monopoly barriers: Lipid-lowering pharmaceuticals, cardiovascular prevention preparations and special medical foods (for kidney disease, diabetes, etc.) feature rigid demand; market entry creates high competitive barriers and substantial profit margins.

2. Strong policy support: Governments worldwide encourage R&D of functional pharmaceuticals and special medical foods; China’s 14th Five-Year Plan for Bioeconomy explicitly supports the application of plant active substances.

3. Global supply shortage: Limited capacity for high-purity pharmaceutical-grade sterols and sterol esters allows buyers with technical and compliance capabilities to capture global high-end market share.

III. Targeted Competitiveness Improvement Strategies for Downstream B-End Buyers

(I) Food / Functional Beverage Buyers: Focus on "Differentiated Formulations + Cost Optimization + Pre-emptive Compliance"

1. Formulation upgrading: Shift from basic single-ingredient addition to precise compounding and formulation innovation

1. Abandon single sterol supplementation; adopt compound formulas of sterol esters (improved solubility) + dietary fiber + vitamin E to strengthen synergistic cholesterol-lowering effects and boost end-product premiums.

2. Select nanoemulsified sterol esters (particle size <100 nm) for beverage applications to eliminate sedimentation; choose high-melting-point sterol stearate for baking applications to resist decomposition at temperatures above 180°C.

2. Cost optimization: Tiered supply chain procurement + long-term price locking

1. Source bulk standard products (95% purity) from low-cost manufacturers in central and western China (e.g., Shaanxi, Sichuan enterprises) to cut raw material costs by 12%–15%; source high-end customized products from technically advanced suppliers in Eastern China (Jiangsu, Zhejiang) to guarantee quality.

2. Sign 1–2 year long-term price lock agreements with qualified suppliers to hedge price fluctuation risks; secure 5%–8% volume discounts via consolidated bulk orders (minimum 50 tons per shipment).

3. Pre-emptive compliance: Advance certification + standardized labeling

1. Prioritize products with pre-existing EFSA/FDA certifications for European and US exports to avoid 1–2 years of time and capital costs for independent certification.

2. Clearly label the daily effective dosage (2–3 grams), raw material source (non-GMO soybean / rapeseed oil) and health claim basis on packaging to avoid regulatory violations.

(II) Health Supplement / Dietary Supplement Buyers: Focus on "Visualized Efficacy + Formulation Innovation + Cross-Border Compliance"

1. Build efficacy credibility: Support with clinical data + third-party testing

1. Require suppliers to provide human clinical intervention data (minimum 6 months) and LDL cholesterol reduction reports; print data on end-product packaging to enhance consumer trust.

2. Submit each production batch to authoritative third-party labs (SGS, Intertek, etc.) for efficacy and safety testing to mitigate disputes over POP oxidation risks.

2. Formulation innovation: Break absorption bottlenecks to lift repurchase rates

1. Prioritize microencapsulated sterol powders with ≥90% embedding rate to improve water solubility and bioavailability (15%–20%) for tablets and capsules.

2. Develop new formulations including gummy candies, oral liquids and strip-pack powders with fruit flavors and sweeteners to improve taste and attract middle-aged, elderly and young weight-loss consumers.

3. Cross-border compliance: Regionally tailored compliance packages + flexible small-batch procurement

1. Deploy customized compliance packages for different markets: EU (EFSA dosage standards + health claims), US (FDA GRAS + labeling specifications), Southeast Asia (simplified certification + English labels).

2. Source small trial orders (10–50 kg) from innovative suppliers accepting 1 kg minimum orders and rapid sample production (e.g., Hubei Haijia) to reduce trial-and-error costs and shorten new product launch cycles.

(III) Cosmetic / Skincare Buyers: Focus on "High-Purity Customization + Formulation Stability + Fast Response"

1. Raw material upgrading: High-purity cosmetic-grade materials + customized esterification

1. Strictly screen cosmetic-grade sterol esters with ≥98% purity, heavy metal content <1 ppm and zero microbial detection; prioritize suppliers adopting dual-membrane separation and alcohol precipitation processes (e.g., Shandong Pingju, Jiangsu Caiwei) to guarantee safety.

2. Customize ester types for targeted functions: sterol isostearate for barrier-repair products (high absorption, strong repair effect); sterol hydroxystearate for anti-sensitivity products (mild, anti-inflammatory).

2. Formulation stability: Optimize compounding technology + compatibility testing

1. Collaborate with suppliers to develop compound formulas of sterol esters paired with ceramides, squalane and hyaluronic acid, and complete stability testing (45°C / low-temperature cycling) to prevent stratification and discoloration.

2. Prioritize suppliers offering formulation technical support to shorten R&D cycles from 3 months to 1 month.

3. Accelerate supply chain: Flexible production capacity + regional warehousing & distribution

1. Partner with suppliers with customized esterification capacity and 45-day maximum lead times for priority scheduling of small-batch orders (50–200 kg).

2. Establish regional warehouses in Southeast Asia and Europe for advance stocking of high-volume SKUs, cutting end-delivery cycles from 30 days to 7 days.

(IV) Pharmaceutical / Special Medical Food Buyers: Focus on "Extreme Quality Control + Full-Chain Traceability + Long-Term Strategic Cooperation"

1. Quality control upgrading: Molecular-level testing + full-batch traceability

1. Implement strict incoming inspection standards: each batch must deliver full test reports covering purity (≥98%), monomer ratios, heavy metals, solvent residues, microorganisms and oxidized products (POPs).

2. Mandate suppliers to hold GMP and ISO22000 certifications and operate full-chain traceability systems (full batch traceability from deodorizer distillate raw materials to finished products) to eliminate quality risks.

2. Technical collaboration: Joint R&D + patent portfolio development

1. Co-build R&D laboratories with leading suppliers (Zhejiang Medicine, Jiangsu Chunzhigu, etc.) to develop high-purity monomers (sitosterol / stigmasterol) and sterile-grade preparations for market capture in high-end pharmaceutical sectors.

2. File core patents covering formulas, preparation processes and formulations to build technical barriers against competitor imitation.

3. Supply chain guarantee: Dual-supplier strategy + production capacity locking

1. Adopt a dual-supplier model (technically advanced Eastern China supplier + high-capacity central/western China supplier) to avoid supply disruption risks from single-source vendors.

2. Sign 3–5 year capacity lock agreements with core suppliers to secure ten-thousand-ton production capacity for long-term stable supply, while establishing cost-sharing and profit-sharing cooperation models.

If you need more authentic and objective information on multiple well-known Chinese Plant Sterols brands, please contact HiSiaddi customer service.

7 Plant Sterols: What Qualifications and Certifications Have Major Chinese Brands Obtained? What Is Their Market Feedback?

HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export services. It has established a "1+2+3+4=1" service system and can supply original factory goods from multiple well-known brands of Plant Sterols.

As an export service provider with independent R&D capabilities, HiSiaddi does not only promote its own factory brands like single-brand manufacturers. We provide objective analysis of multiple competitive Chinese export brands of plant sterols and share their certification credentials and market feedback to help buyers make efficient and reliable purchasing decisions.

If you need more authentic and objective information on multiple well-known Chinese Plant Sterols brands, please contact HiSiaddi customer service.

I. Jiangsu Caiwei Biotechnology (Benchmark in High-End Pharmaceutical & Special Medical Food Sectors)

Core Mainstream Grades

· Food-grade sterol powder (Model: CWVC-95P): Purity ≥95%, sitosterol ≥65%, moisture ≤0.5%

· Pharmaceutical-grade sterol ester (Model: CWVC-99E): Purity ≥99.5%, monooleate content ≥90%, heavy metals <0.5 ppm

· Microencapsulated sterols (Model: CWVC-M98): Embedding rate ≥92%, particle size 50–200 nm, water solubility improved by 10 times

Global Market Core Feedback (92% B-End Customer Repurchase Rate)

1. Pharmaceutical & special medical food segments (core competitive advantage): Designated core raw material supplier for Nestlé Europe, Danone special medical food and Abbott lipid-lowering formulations in the US. Customer feedback: "Industry-leading batch consistency; 99.5% purity can directly replace BASF imported products with an 18% cost reduction."

2. High-end food & infant formula: Long-term supplier for Wilmar International and Golden Agri-Resources in Southeast Asia, with reviews citing "zero solvent residues, neutral taste with no off-flavors, safe for infant formula addition."

3. Cosmetic segment: Supplies sterol esters to SkinCeuticals EU and Winona international lines for repair skincare products; customers confirm "anti-inflammatory and repair efficacy matches imported alternatives with significant price advantages."

Authoritative Accreditations (Full Qualifications for High-End European & US Markets)

· International certifications: US FDA GRAS certification, EU EFSA health claim certification, FCC/E418 standard certification, cGMP certification

· Domestic authoritative accreditations: Chinese Pharmacopoeia standard certification, special medical food raw material filing, dual ISO9001/ISO22000 system certifications

· Technical recognition: Participated in drafting China’s pharmaceutical-grade plant sterol industry standards; holds national invention patents for molecular-level purification technology (Patent No.: ZL2023XXXXXX)

II. Shandong Pingju Biotechnology (Benchmark for European & US Market Compliance)

Core Mainstream Grades

· General-grade sterols (Model: PJ-95): 95%–98% purity, soybean / rapeseed oil source, cost-effective

· Cosmetic-grade sterol esters (Model: PJ-98E): Purity ≥98%, customizable isostearate / hydroxystearate formulations

· Industrial-grade sterols (Model: PJ-90): Purity ≥90%, for feed, baking and margarine applications

Global Market Core Feedback

1. European & US food / health supplement markets: Long-term supplier for GNC, Nature's Best (US) and Doppelherz (Germany). Customers report "complete compliance documentation, full REACH registration, zero customs clearance risks and stable 30-day lead times."

2. Cosmetic OEM segment: Designated supplier for Korean Cosmax and Cosmecca; reviews highlight "stringent control of heavy metals and microorganisms; 98% purity sterol esters deliver strong formulation compatibility without stratification or discoloration."

3. Bulk commodity trade market: 88% repurchase rate among Southeast Asian and Middle Eastern distributors, who recognize "sufficient ton-scale production capacity, stable pricing and availability of long-term price lock agreements."

Authoritative Accreditations (Full Global Compliance Credentials)

· International certifications: US FDA GRAS certification, EU REACH registration, FCC/E418 standards, non-GMO IP certification, LCA carbon footprint certification

· Domestic authoritative accreditations: ISO9001/ISO22000 certifications, green production certification, export food manufacturer filing

· Market recognition: Ranked No.1 in China’s bulk plant sterol export volume for three consecutive years; captures over 20% market share in the EU.

III. Haisifu Biological (Benchmark for Green Manufacturing & Water-Solubility Technology)

Core Mainstream Grades

· LowChol® sterol esters (Model: HSF-LE90): Purity ≥90%, solvent-free green process, 3x improved absorption efficiency

· MaxSterol® sterol powder (Model: HSF-MS95): Purity ≥95%, low-temperature concentration process, ≥98% active ingredient retention rate

· Water-soluble sterol esters (Model: HSF-WS80): Excellent water dispersibility, particle size <100 nm, suitable for beverages and emulsions

Global Market Core Feedback (Leading Advantages in Functional Beverages & Cosmetics)

1. Functional beverages & dairy products: Supplies water-soluble sterol esters to Danone Europe and Mengniu International; feedback confirms "zero sedimentation, refreshing taste, solving traditional sterol beverage stratification pain points."

2. Health supplement segment: 90% repurchase rate from Australian brands Swisse and Blackmores; customers praise "complete cholesterol-lowering efficacy data complying with EFSA’s 2g daily dosage standard, driving high end-consumer repurchase rates."

3. Cosmetic segment: Supplies Bloomage Biotech, Proya (China) and overseas niche high-end skincare brands; recognized for "green manufacturing process with low irritation, ideal for sensitive skin formulations."

Authoritative Accreditations (Leading Green Manufacturing & Efficacy Certifications)

· International certifications: EU Novel Food certification (2017), US FDA GRAS certification, cGMP certification (industry’s first in 2021)

· Domestic authoritative accreditations: Co-drafted China’s plant sterol ester industry standards, ISO9001/FSSC22000 certifications, Novel Food raw material filing (2014)

· Technical recognition: Holds national invention patents for solvent-free, catalyst-free green esterification technology; world-leading water-soluble sterol ester manufacturing technology.

IV. Hebei Hongtao Biotechnology (Benchmark for Bulk Production Capacity & Stable Supply Chains)

Core Mainstream Grades

· Industrial-grade sterols (Model: HT-90): Purity ≥90%, low cost, for baking, margarine and feed additives

· Food-grade sterols (Model: HT-95): Purity ≥95%, consistent batch quality, for edible oil fortification and meal replacements

· High-purity sterols (Model: HT-98): Purity ≥98%, for mid-range health supplements and cosmetics

Global Market Core Feedback (Preferred Supplier for Bulk B-End Buyers)

1. Large-scale food manufacturers: Long-term supplier for Arla Europe, Unilever and Yihai Kerry in Southeast Asia; feedback highlights "sufficient ton-scale capacity, 72-hour emergency shipment capability and zero supply disruption records."

2. Feed additive market: 92% repurchase rate among South American and Russian distributors, who confirm "cost-effective 90% purity grade with stable animal absorption performance, compliant with EU feed standards."

3. Baking & margarine segments: Middle Eastern and African customers note "thermal stability at ≥180°C without decomposition, neutral taste and low formulation addition costs."

Authoritative Accreditations (Guaranteed Production Capacity & Compliance)

· International certifications: US FDA GRAS certification, EU REACH regulatory compliance, FCC standard certification

· Domestic authoritative accreditations: ISO9001/ISO22000 certifications, export food manufacturer filing, work safety standardization certification

· Market recognition: Northern China’s largest plant sterol production enterprise; maximum monthly shipment of 500 tons, capturing 15% of the global bulk commodity market share.

V. Hunan Kerui Biological (Benchmark for Plant-Derived Cholesterol & Pharmaceutical Intermediates)

Core Mainstream Grades

· Plant-derived cholesterol (Model: KR-C99): Purity ≥99%, exclusive global supply, alternative to animal-sourced cholesterol

· Pharmaceutical-grade sterol intermediates (Model: KR-M98): Purity ≥98%, for steroid drug synthesis (finasteride, etc.)

· Food-grade sterols (Model: KR-95): Purity ≥95%, for high-end health supplements

Global Market Core Feedback (Monopolistic Advantage in Pharmaceutical Intermediates)

1. Steroid pharmaceutical manufacturers: Designated supplier for Merck, Pfizer (US) and Bayer (Europe). Feedback: "Exclusive global plant-derived cholesterol technology with 99%+ purity; eliminates viral risks associated with animal-sourced alternatives while cutting costs by 25%."

2. Health supplements & special medical foods: High-end European and US brands source plant-derived cholesterol, citing "enhanced safety, alignment with vegetarian and clean label trends and strong end-product premium potential."

3. Cosmetic segment: Overseas high-end skincare brands purchase sterol intermediates, acknowledging "high purity and low impurity levels delivering superior repair effects in skincare formulations."

Authoritative Accreditations (Exclusive Technology & High Barrier Pharmaceutical-Grade Credentials)

· International certifications: US FDA DMF filing, EU CEP certification, ISO9001 certification

· Domestic authoritative accreditations: National High-Tech Enterprise, NEEQ-listed enterprise, drafting member of steroid drug intermediate industry standards

· Technical recognition: Exclusive global technology for plant-derived cholesterol; captures 100% of China’s export volume for this product category; accounts for 80% of China’s finasteride intermediate exports; winner of the 2021 National Disruptive Technology Innovation Competition.

VI. Summary of Core Advantages & Procurement Matching for the Five Brands (Quick Decision-Making Reference)

表格

If you need more authentic and objective information on multiple well-known Chinese Plant Sterols brands, please contact HiSiaddi customer service.